Treatment of Non-Public Information. Each Investor covenants and agrees with the Company (a) to hold the existence, terms and conditions of the transactions contemplated by this Agreement in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a Current Report on Form 8-K disclosing the offering or publicly announces the offering, and (b) to hold all matters disclosed to it by the Company (other than any matters included in the SEC Reports) in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a report publicly disclosing such information. Each Investor understands that the federal securities laws impose restrictions on trading based on information regarding the transactions contemplated by this Agreement.
Treatment of Non-Public Information a. Data Recipient agrees to take all reasonable precautions to maintain the confidentiality of the Non-Public Information and to prevent unauthorized access to it.
Treatment of Non-Public Information. The Investor agrees to hold the existence, terms and conditions of the Offering in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a Current Report on Form 8-K disclosing the Offering or publicly announces the Offering.
Treatment of Non-Public Information. Data Recipient agrees to treat Non-Public Information in accordance with the following terms:
Treatment of Non-Public Information. Pfizer agrees (a) to hold the existence, terms and conditions of this Agreement, the Collaboration Agreement and the transactions contemplated hereby and thereby in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a Current Report on Form 8-K disclosing such matters or publicly announces the same, and (b) to hold certain other matters disclosed to it by the Company in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a report publicly disclosing such information. Pfizer understands that the federal securities laws impose restrictions on trading based on information regarding such matters.
Treatment of Non-Public Information. Such Investor agrees to hold the existence, terms and conditions of the Transaction in confidence and not to disclose the same to any other person, other than its representatives, agents and employees who are made aware of such agreement, until such time as the Company files with the Commission a Current Report on Form 6-K disclosing the Transaction or publicly announces the Transaction.
Treatment of Non-Public Information. 2.1 Data Recipient agrees not to disclose or permit to be disclosed any Non-Public Information, other than to or amongst:
Treatment of Non-Public Information. The Purchaser agrees to hold the existence, terms and conditions of this Agreement in confidence and not to disclose the same to any other person until such time as the Company files the 8-K Filing (as defined below). On or before 8:30 a.m., New York City time, on the first business day following the date of this Agreement, the Company shall issue a press release and file a Current Report on Form 8-K describing the material terms of the transactions contemplated by this Agreement in the form required by the Exchange Act (the “8-K Filing”). From and after the filing of the 8-K Filing with the SEC, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any of its subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the 8-K Filing.
Treatment of Non-Public Information. The Purchaser agrees (a) to hold the existence, terms and conditions of the Offering in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a Current Report on Form 8-K disclosing the Offering or publicly announces the Offering, and (b) to hold certain other matters disclosed to it by the Company in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a report publicly disclosing such information. The Purchaser understands that the federal securities laws impose restrictions on trading based on information regarding this Offering.
Treatment of Non-Public Information. The Investor agrees (a) to hold the existence, terms and conditions of the Offering in confidence and not to use or disclose the same to any other person until such time as the Company files with the SEC a Current Report on Form 8-K disclosing the Offering or publicly announces the Offering, and (b) to hold certain other matters disclosed to it by the Company in confidence and not to disclose the same to any other person until such time as the Company files with the SEC a report publicly disclosing such information, in accordance with the terms of the Confidentiality and Nondisclosure Agreement previously entered into between the Company and the Investor.
